STE
STERIS plc
$232.97
-3.80
(-1.60%)
Mkt Cap
22.70B
Volume
532,577
52W Range
195.14-269.44
Sector
Healthcare
Beta
0.91
EPS (TTM)
8.20 USD
P/E Ratio
28.41
Revenue (TTM)
6.04B USD
Rev Growth (5Y)
+13.8%
EPS Growth (5Y)
+11.2%
AlphaVal · Fair Value
What we estimate one share is worth
$178.98
Overvalued
moderate signal
30.2% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B
Platform & Compounding FCF
69.6 / 100 composite
A platform business that compounds free cash flow — graded A–F vs. similar companies.
Company Description
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. It also provides services such as equipment maintenance, instrument repair, and contract sterilization for medical device and pharmaceutical manufacturers.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.94B | 5.46B | 5.14B | 4.54B | 4.22B | 3.11B | 3.03B | 2.78B | 2.62B | 2.61B | 2.24B | 1.85B |
| Net Income | 785.10M | 614.64M | 378.24M | 107.03M | 243.89M | 397.40M | 407.66M | 304.05M | 290.92M | 109.97M | 110.76M | 135.06M |
| EPS | 7.93 | 6.24 | 3.83 | 1.07 | 2.50 | 4.66 | 4.81 | 3.59 | 3.42 | 1.29 | 1.57 | 2.27 |
| Free Cash Flow | 972.40M | 778.00M | 612.95M | 394.98M | 397.25M | 450.38M | 376.04M | 349.79M | 292.18M | 251.19M | 128.27M | 160.78M |
| FCF / Share | 9.90 | 7.89 | 6.20 | 3.96 | 4.07 | 5.29 | 4.44 | 4.14 | 3.44 | 2.94 | 1.81 | 2.71 |
| Operating CF | 1.34B | 1.15B | 973.27M | 756.95M | 684.81M | 689.64M | 590.56M | 539.50M | 457.63M | 424.09M | 254.68M | 246.04M |
| Total Assets | 10.74B | 10.15B | 11.06B | 10.82B | 11.42B | 6.57B | 5.44B | 5.07B | 5.20B | 4.92B | 5.35B | 2.10B |
| Total Debt | 2.09B | 2.20B | 3.38B | 3.25B | 3.28B | 1.80B | 1.28B | 1.18B | 1.32B | 1.48B | 1.57B | 621.08M |
| Cash & Equiv | 439.60M | 171.70M | 207.02M | 208.36M | 348.32M | 220.53M | 319.58M | 220.63M | 201.53M | 282.92M | 248.84M | 167.69M |
| Book Value | 7.18B | 6.60B | 6.30B | 6.08B | 6.53B | 3.88B | 3.41B | 3.18B | 3.21B | 2.80B | 3.02B | 1.07B |
| Return on Equity | 0.11 | 0.09 | 0.06 | 0.02 | 0.04 | 0.10 | 0.12 | 0.10 | 0.09 | 0.04 | 0.04 | 0.13 |
| Metric | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.49B | 1.59B | 1.50B | 1.46B | 1.39B | 1.48B | 1.37B | 1.33B | 1.28B | 1.12B | 1.30B | 1.24B |
| Net Income | 200.10M | 220.30M | 192.80M | 191.90M | 177.40M | 145.67M | 173.53M | 150.03M | 145.40M | (1.38M) | 140.74M | 115.32M |
| EPS | 2.05 | 2.24 | 1.96 | 1.95 | 1.80 | 1.48 | 1.76 | 1.52 | 1.47 | -0.01 | 1.42 | 1.17 |
| Free Cash Flow | 279.60M | 245.20M | 199.50M | 201.30M | 326.40M | 189.90M | 243.61M | 148.89M | 195.60M | 163.31M | 172.31M | 62.80M |
| FCF / Share | 2.86 | 2.50 | 2.03 | 2.05 | 3.32 | 1.93 | 2.47 | 1.51 | 1.98 | 1.65 | 1.74 | 0.64 |
| Operating CF | 367.10M | 335.40M | 298.20M | 287.80M | 420.00M | 260.78M | 332.84M | 250.77M | 303.70M | 254.81M | 291.24M | 146.09M |
| Total Assets | 10.74B | 10.74B | 10.59B | 10.41B | 10.40B | 10.15B | 10.01B | 10.24B | 10.11B | 11.06B | 11.44B | 11.28B |
| Total Debt | 2.04B | 2.09B | 2.05B | 2.06B | 2.07B | 2.20B | 2.32B | 2.40B | 2.48B | 3.38B | 3.51B | 3.63B |
| Cash & Equiv | 482.30M | 439.60M | 423.70M | 319.20M | 279.70M | 171.70M | 155.18M | 172.19M | 198.33M | 207.02M | 195.59M | 213.76M |
| Book Value | 7.21B | 7.18B | 7.17B | 7.01B | 6.96B | 6.60B | 6.42B | 6.59B | 6.35B | 6.30B | 6.42B | 6.18B |
| Return on Equity | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | 0.02 | 0.02 | -0.00 | 0.02 | 0.02 |
STE News
Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?
Should Investors Buy STERIS as Growth Meets Reasonable Valuation?
STERIS Q1 Earnings Call Highlights
STERIS Q1 Earnings Call Highlights
STERIS plc (STE) Q1 2027 Earnings Call Transcript
STE Q1 Earnings Beat, Revenues Miss, Stock Dips in Aftermarket Trading
5 Quality Stocks Set to Reward Investors With Dividend Hikes
Here's What Key Metrics Tell Us About Steris (STE) Q1 Earnings
Steris (STE) Q1 Earnings Surpass Estimates
STERIS Announces Financial Results for Fiscal 2027 First Quarter